查詢結果分析
相關文獻
- 運用創新策略降低中心導管相關血流感染
- 導入組合式感染管制措施以降低中心導管相關血流感染
- 提升加護病房醫護人員執行中心導管組合式介入措施之完整率
- 運用跨領域團隊組合式照護改善內科加護病房中心導管相關血流感染率
- 應用組合式照護預防中心導管相關血流感染
- 以組合式(Bundle)感染管制措施預防中心導管相關血流感染
- 某醫學中心Serratia marcescens中心導管相關血流感染重症病人之死亡預測因子與分離株抗生素敏感性分析
- 接受全靜脈營養的成人病人發生中心導管相關血流感染之危險因子的臨床研究
- 運用組合式照護降低重症加護單位中心導管相關血流感染率
- 使用Chlorhexidine擦澡對中心導管相關血流感染之統合分析
頁籤選單縮合
題名 | 運用創新策略降低中心導管相關血流感染=Implementation of Innovative Strategies to Reduce Central Line Associated Bloodstream Infections |
---|---|
作者 | 呂淑如; 張寶綾; 陳瑞儀; 蔡佩真; 楊淑惠; 古世基; 洪儀珍; 黃筱芳; 鄭之勛; 高秀娥; Lu, Shu-ju; Chang, Bao-lin; Chen, Jui-yi; Tsai, Pei-chen; Yang, Shu-hui; Ku, Shih-chi; Hung, I-chen; Huang, Hsiao-fang; Jerng, Jih-shuin; Kao, Hsiu-o; |
期刊 | 臺灣醫學 |
出版日期 | 20191100 |
卷期 | 23:6 2019.11[民108.11] |
頁次 | 頁758-768 |
分類號 | 419.38 |
語文 | chi |
關鍵詞 | 中心導管; 導管相關血流感染; 感染控制; Central line; Central line associated bloodstream infections; Infection control; |
中文摘要 | 本專案旨在降低中心導管相關血流感染,動機係因本單位中心導管相關血流感染2017年第三季(千分之8.3),高於醫學中心同儕,經現況分析導因有:病人免疫功能低下、主要感染菌種為革蘭氏陰性菌、靜脈抗生素治療比率高、醫師未落實判定導管適應症、單位無逐案分析感染病人機制、置入物品置放零散。經專案小組與專家研商,擬訂創新策略為「車、車、車、車畚掉」,包含:PICC置入、CHG抗菌敷料、制定逐案分析制度、中心導管置入專用工作車、β-lactam抗生素延長輸注、修正中心導管拔掉步驟。經專案推動,中心導管相關血流感染2018年前三季(千分之5.0),均達到設定目標(千分之7.0);建議平行推廣以促進重症單位之照護品質。 |
英文摘要 | This program aimed to reduce the incidence of central line-associated bloodstream Infections (CLABSI), as a higher CLABSI incidence of (8.3 per mille) was observed at the medical respiratory care center in the 3rd quarter of 2017, which was higher than peer medical centers. Underlying reasons to contribute to this trend include patients' immune-compromised status, Gram-negative bacteria as the main pathogen, high prevalence of intravenous antibiotic use, physicians' incomplete compliance to specify the indication to use central lines, lack of a mechanism to analyze the cases with infection, and the presence of scattered items at the care scene. After the discussion and analysis with a group of experts, we proposed innovative strategies including the implementation of peripherally inserted central catheters (PICC) placement, provision of antimicrobial wound dressing with chlorhexidine gluconate, development of case analysis system, deployment of a dedicated cart for central line placement, prolongation of infusion time of β-lactams, and revision of process for the removal of the central line. After the implementation of these strategies, the CLABSI incidence was reduced to (5.0 per mille) in the first three quarters of 2018, which were all reached the target level below (7.0 per mille). Therefore, hoping for generalization, we recommend a spreading of these strategies to other critical care units to enhance the quality of care. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。